Skip to content

Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)

Urinary Albumin Excretion in Women With Polycyclic Ovary Syndrome and it's Relation to Cardiovascular Risk Factors

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02569164
Enrollment
50
Registered
2015-10-06
Start date
2015-10-31
Completion date
2015-12-31
Last updated
2015-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Albumin Excretion

Brief summary

PCO patients will be assessed clinically,urine & blood samples will be tested. Systolic & diastolic blood pressure, serum glucose & insulin levels, lipid profile, C-reactive protein, complete hormonal profile, and Urinary albumin excretion will be measured.

Detailed description

PCO patients with 2 of 3 criteria: oligo- or anovulation ; hyperandrogenism &polycystic ovaries. Exclusion criteria: pregnancy, diabetes, hypertension , adrenal & thyroid dysfunction. Blood samples after overnight fast (8hrs) at day 2 or 3 of menstrual cycle. Serum concentration of follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin, total testosterone & sex hormone binding globulin, serum 17-hydroxy (OH) progesterone & dehydroepiandrosterone sulfate will be measured. Oral glucose tolerance test & plasma insulin levels will be measured. Total cholesterol, triglycerides, high& low density lipoproteins. Urinary albumin will be measured& all the data will be analysed.

Interventions

None listed

Sponsors

Kasr El Aini Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* PCO patients

Exclusion criteria

* pregnancy * diabetes * hypertension * adrenal dysfunction * thyroid dysfunction

Design outcomes

Primary

MeasureTime frame
Number of patients with hyperinsulinemia (uIU/ml)3 months
Number of patients with hyperlipidemia (mg/dl).3 months
Number of patients with albuminuria(ug/ml)3 months

Contacts

Primary Contactsuzy abdelaziz, M.D.
suzyabdelaziz92@gmail.com01003726195

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026